Published in Clinical Oncology Week, April 14th, 2008
"The method of immunization will confer significant properties to the potency of the vaccine and might require augmentation with certain adjuvant agents like interieukin-12 and granulocyte-macrophage colony-stimulating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.